Palliative Care of Malignant Ureteral Obstruction with Polytetrafluoroethylene Membrane-Covered Self-Expandable Metallic Stents: Initial Experience

다국어 초록 (Multilingual Abstract)

Purpose: We assessed the efficacy and safety of insertion of a polytetrafluoroethylene membrane-covered self-expandable metallic stent (UVENTA stent) for palliation of malignant ureteral obstruction on the basis of our early results.
Materials and Methods: Eighteen patients underwent UVENTA stent insertion for extrinsic malignant ureteral obstructions of 20 ureters. The UVENTA stents were deployed retrogradely under cystoscopy and fluoroscopy. Candidates for the procedure had preexisting double-J stents that were nonfunctional or caused excessive bladder irritation. We recorded the success and patency rate in addition to any complications associated with the procedure.
Results: The mean length of obstruction was 10.6 cm (range, 2 to 20 cm). Two ureters were obstructed in the upper ureter, 9 in the lower ureter, and 9 in multiple levels of ureter. Simultaneous balloon dilation was performed in 12 ureters. UVENTA stents were successfully inserted in all patients. No obstruction of the UVENTA stents occurred during the mean follow-up period of 7.3 months (patency rate 100%), but de novo ureteral obstruction developed in 4 ureters. There were no instances of stone formation, hyperplastic reaction, encrustation, or migration. Abnormally elevated serum creatinine decreased to normal levels and hydronephrosis gradually resolved during the 4 weeks after UVENTA insertion. No significant complications developed except for transient and self-limiting hematuria and mild lower abdominal pain.
Conclusions: UVENTA stents may relieve malignant ureteral obstruction safely and easily. Long-term follow-up is necessary to assess the role of this stent in the treatment of malignant ureteral obstruction.

다국어 초록 (Multilingual Abstract)

Purpose: We assessed the efficacy and safety of insertion of a polytetrafluoroethylene membrane-covered self-expandable metallic stent (UVENTA stent) for palliation of malignant ureteral obstruction on the basis of our early results.
Materials and Methods: Eighteen patients underwent UVENTA stent insertion for extrinsic malignant ureteral obstructions of 20 ureters. The UVENTA stents were deployed retrogradely under cystoscopy and fluoroscopy. Candidates for the procedure had preexisting double-J stents that were nonfunctional or caused excessive bladder irritation. We recorded the success and patency rate in addition to any complications associated with the procedure.
Results: The mean length of obstruction was 10.6 cm (range, 2 to 20 cm). Two ureters were obstructed in the upper ureter, 9 in the lower ureter, and 9 in multiple levels of ureter. Simultaneous balloon dilation was performed in 12 ureters. UVENTA stents were successfully inserted in all patients. No obstruction of the UVENTA stents occurred during the mean follow-up period of 7.3 months (patency rate 100%), but de novo ureteral obstruction developed in 4 ureters. There were no instances of stone formation, hyperplastic reaction, encrustation, or migration. Abnormally elevated serum creatinine decreased to normal levels and hydronephrosis gradually resolved during the 4 weeks after UVENTA insertion. No significant complications developed except for transient and self-limiting hematuria and mild lower abdominal pain.
Conclusions: UVENTA stents may relieve malignant ureteral obstruction safely and easily. Long-term follow-up is necessary to assess the role of this stent in the treatment of malignant ureteral obstruction.

참고문헌 (Reference)

1 Russo P, "Urologic emergencies in the cancer patient" 27 : 284-298, 2000

2 Lau MW, "Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease" 76 : 565-569, 1995

3 Russo P, "Ureteral obstruction and stents: still a difficult problem for patients and urologists alike" 174 : 2088-, 2005

4 Liatsikos EN, "Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment" 182 : 2613-2617, 2009

5 Agrawal S, "The thermo-expandable metallic ureteric stent: an 11-year follow-up" 103 : 372-376, 2009

6 Arya M, "The self-expanding metallic ureteric stent in the long-term management of benign ureteric strictures" 88 : 339-342, 2001

7 Watkinson AF, "The role of percutaneous nephrostomy in malignant urinary tract obstruction" 47 : 32-35, 1993

8 Hepperlen TW, "The pigtail ureteral stent in the cancer patient" 121 : 17-18, 1979

9 Ganatra AM, "The management of malignant ureteral obstruction treated with ureteral stents" 174 : 2125-2128, 2005

10 Emmert C, "Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer" 259 : 147-151, 1997

11 Trueba Arguinarena FJ, "Self-expanding polytetrafluoroethylene covered nitinol stents for the treatment of ureteral stenosis: preliminary report" 172 : 620-623, 2004

12 Burgos FJ, "Self-expanding metallic ureteral stents for treatment of ureteral stenosis after kidney transplantation" 37 : 3828-3829, 2005

13 Gillams A, "Self-expandable stainless steel braided endoprosthesis for biliary strictures" 174 : 137-140, 1990

14 Yachia D, "Recent advances in ureteral stents" 18 : 241-246, 2008

15 Aravantinos E, "Percutaneous nephrostomy in patients with tumors of advanced stage: treatment dilemmas and impact on clinical course and quality of life" 21 : 1297-1302, 2007

16 Liatsikos EN, "Metal stents in the urinary tract" 5 : 77-88, 2007

17 Barbalias GA, "Externally coated ureteral metallic stents: an unfavorable clinical experience" 42 : 276-280, 2002

18 Finney RP, "Experience with new double J ureteral catheter stent" 120 : 678-681, 1978

19 Klarskov P, "Experience with Memokath 051 ureteral stent" 39 : 169-172, 2005

20 Tekin MI, "Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results" 58 : 919-923, 2001

21 Chung HH, "Comparison of a new polytetrafluoroethylene-covered metallic stent to a noncovered stent in canine ureters" Springer 31 (31): 619-628, 2008

22 Dindo D, "Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey" 240 : 205-213, 2004

23 Chung SY, "15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents" 172 : 592-595, 2004